Skip to main content
MedPathMedPath Home
Clinical Trials/PACTR202007730554581
PACTR202007730554581
Completed
Phase 4

Characterization of muscle fatigue, rehabilitation and quality of life in a population with breast cancer.

APERE0 sites39 target enrollmentMay 26, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCancer

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Cancer
Sponsor
APERE
Enrollment
39
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Compared to controls, a significant increase in the WS (P < 0.01) and the WD (P < 0.01) accompanied by a significant decrease in resting rHR (P < 0.01), exercising HR6' (P < 0.01), [La]b (P < 0.05), HR6'/WS (P < 0.01) and [La]b/WS ratios (P < 0.01) was reported in the trained group. However, a significant decrease both in WD (P < 0.01) and WS (P < 0.01) has been observed in the controls. No significant difference was observed in resting HR, exercising HR6', [La]b, HR6'/WS, and [La]b/WS ratios were observed in the control group. A significant improvement was observed for RPE in training group (P < 0.05).

Registry
who.int
Start Date
May 26, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
APERE

Eligibility Criteria

Inclusion Criteria

  • •Women aged from 18 to 65 years.
  • •\- No known history of chronic respiratory, cardiac or neuromuscular disease.
  • •\- Diagnosed with non\-metastatic breast cancer (stage y–IIIA).
  • •\- Women who have had a mastectomy and are in the process of adjuvant chemotherapy (postoperative).

Exclusion Criteria

  • •\- Hemoglobin concentration \< 8 g/dL, platelet count \< 20/nL.
  • •\- Obesity \[body mass index (BMI) \> 30].
  • •\- Malnutrition (BMI \< 20\).
  • •\- Treatment with high\-dose corticoids (prednisone \> 50 mg/day or equivalent dose of related agents).
  • •\- Chronic infection, neurological or muscular impairment.
  • •\- chronic diseases that could be exacerbated by exercise (coronary artery disease, chronic obstructive pulmonary
  • •disease, osteoarthritis), skeletal metastases resulting in bone instability, or progressive disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Comparison of Different Forms of Recovery on the Functionality After Physical ExerciseMassageInflammatory ResponseMuscle, SkeletalCryotherapy EffectFunctional Disturbance
NCT04201977Universidade Federal de Santa Maria50
Completed
Not Applicable
Improvements in muscle recovery and delayed onset muscle soreness (DOMS) reduction after eccentric exercise with the BounceBack™ product: a randomised, double-blind, two-way crossover, placebo-controlled, pilot study
ISRCTN59915743Mannatech, Inc (USA)10
Completed
Not Applicable
Fatigue, and changes to muscle strength and physical function in delayed versus immediate exercise for breast cancer survivors scheduled for radiation therapy: A randomised controlled trial
ACTRN12612000646842Edith Cowan University100
Completed
Not Applicable
Effectiveness of Distal and Proximal Muscle Fatigue for Healthy Young AdultsHealthyYoung AdultFatigue
NCT06181071Saglik Bilimleri Universitesi26
Unknown
Not Applicable
Improvement of Neuromuscular Function, Fatigue and Quality of Life by Optimizing Muscle Building and Nutrition in Colorectal Cancer: a Pilot StudyCancerCachexia; Cancer
NCT04136249Ramsay Générale de Santé30